Monash University researchers discovered a method for reprogramming lupus patients' defective cells using healthy individuals' protective molecules, offering potential treatment for lupus and other autoimmune diseases.

Monash University researchers have discovered a method for reprogramming defective cells in lupus patients using protective molecules from healthy individuals. This advancement offers hope for effective long-term treatment of lupus, a debilitating autoimmune disease with no cure and limited treatment options. While tested on human cells, the researchers believe the method can also be applied to treat other autoimmune diseases such as diabetes, rheumatoid arthritis, and multiple sclerosis.

February 06, 2024
9 Articles

Further Reading